Written by Dr. Simon Khela MBChB MRCGP, GMC Registered Doctor
Last reviewed: 05-08-2026
_________________________________________________________________________
At Private Medical Clinic, we fully support the decision to implement stricter weight-loss jab checks for online pharmacies. These new regulations ensure that weight-loss injections, such as Wegovy (semaglutide) and Mounjaro (tirzepatide), are prescribed safely and responsibly. Patients can no longer obtain private prescriptions simply by filling out an online form; instead, they must undergo a video consultation or provide medical records to confirm their body mass index (BMI) and overall suitability for treatment.
This blog post explains what these new prescribing criteria mean for both patients and online pharmacies, why weight-loss medications are now considered high-risk medications, and how these changes align with our commitment to safe and effective private healthcare.
The new rules do not ban online prescribing of Mounjaro or other weight-management medicines. They require online prescribers and pharmacies to carry out stronger checks before treatment is supplied.
A medicine should not be prescribed solely because a patient has entered a height, weight and medical history into an online form. The prescriber must independently verify important information, assess whether treatment is clinically suitable and provide a genuine two-way consultation in which the patient can ask questions.
The updated safeguards published by the General Pharmaceutical Council focus on preventing medicines from being supplied to people whose BMI, health history or treatment risks have not been properly checked.
The General Pharmaceutical Council (GPhC) introduced these stricter regulations following growing concerns about unsafe prescribing practices. Investigations found that some online pharmacies were issuing prescriptions to patients who didn't meet the medical criteria, including individuals with a healthy BMI or a history of eating disorders.
Additionally, reports revealed that certain pharmacies had internal prescription targets, leading to rushed and potentially unsafe prescribing. These new rules ensure that weight-loss injections are only given to those who genuinely need them, helping to reduce health risks and medication shortages.
At Private Medical Clinic, patient safety is our top priority. That's why we welcome these changes and encourage individuals looking for safe, medically supervised weight-loss solutions.
Under the updated regulations, online pharmacies must:
These rules apply not only to weight-loss medications like Wegovy and Mounjaro but also to other high-risk medications, including antimicrobials, laxatives, and opioids.
A video consultation may be used to verify identity, weight and BMI, but the rule is broader than simply requiring every patient to attend a video call. The provider must use a reliable and proportionate method to independently confirm the information on which the prescribing decision depends.
Depending on the service and the patient’s circumstances, this may involve a live video or face-to-face assessment, access to suitable medical records, or other credible evidence. A questionnaire can still form part of the assessment, but it should not be the only source of information.
Patients should be cautious of any provider that promises medication immediately without verifying BMI, reviewing medical history or offering access to a qualified prescriber.
A declined prescription does not necessarily mean the service is being unhelpful. It may indicate that the prescriber cannot confirm treatment is safe or appropriate from the information available.
Common reasons include:
The patient is requesting an inappropriate dose, restarting after a long gap or seeking overlapping prescriptions.
Where suitability is uncertain, a clinician may suggest a broader health assessment or targeted blood tests before deciding whether treatment is appropriate.
Patients seeking private prescriptions for weight-loss injections must now undergo a proper consultation process, ensuring that only those who truly need the medication receive it.
Since pharmacies must verify BMI and medical history, obtaining a prescription may take longer. However, this ensures patients receive safe and effective treatments.
With stricter checks, the risk of inappropriate prescribing and misuse is greatly reduced. Individuals with a history of eating disorders or a healthy BMI will no longer be able to obtain weight-loss jabs without medical justification.
To explore medically supervised weight-loss solutions, visit our medical weight-loss blogs.
A safe consultation should look beyond the number on the scales. Weight-management medicines affect appetite, digestion and blood glucose, and their suitability depends on the patient’s wider health.
A clinician should normally consider.
Patients considering treatment can read about a medically supervised weight-management programme, including the assessment and monitoring expected before and during treatment.
Online pharmacies must now arrange video consultations or verify information through GP records instead of relying on self-reported questionnaires.
Pharmacies must ensure they do not promote weight-loss medications misleadingly. They must follow guidelines from the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Advertising Standards Authority (ASA).
Pharmacies should ensure patients are supported throughout their weight-loss journey, including ongoing monitoring and post-prescription care.
At Private Medical Clinic, we offer comprehensive patient support throughout their weight-loss journey. Learn more about our weight loss services.
No. The medicine’s licence, professional prescribing standards and individual safety checks apply wherever treatment is prescribed, but NHS access criteria and private prescribing decisions are not identical.
NHS eligibility is influenced by NICE recommendations, local commissioning and phased implementation. NICE recommends tirzepatide alongside dietary support and physical activity for particular groups, while NHS England has introduced access in stages. A private prescription still requires an individual clinical assessment, but NHS funding criteria do not automatically determine whether a private prescriber can prescribe.
The current NICE guidance on tirzepatide explains the NHS eligibility framework and phased access.
Prescription-only medicines cannot be advertised directly to the public. This restriction applies even when an advert avoids naming a medicine but uses wording, images or claims that clearly suggest a prescription weight-loss injection.
Providers may advertise a general weight-management consultation or service, but the advert must not be constructed in a way that promotes a specific prescription-only medicine. In September 2025, the MHRA, ASA and GPhC reinforced these rules and warned against phrases such as “weight-loss injection”, “obesity treatment jab” and “GLP-1” in consumer advertising where they promote prescription medicines.
The MHRA and partner enforcement update provides further detail for providers and patients.
Before sharing medical information or paying for treatment, patients should check:
A very low price, instant approval or the absence of meaningful clinical questions should be treated as warning signs rather than benefits.
At Private Medical Clinic, we fully support these stricter weight-loss jab checks to ensure safe and responsible prescribing. While the new rules may require extra verification steps, they ultimately protect patients and ensure weight-loss injections like Wegovy and Mounjaro are used appropriately.
If you're considering a private prescription for a weight-loss jab, choose a trusted healthcare provider that follows these regulations. Learn more about our safe and medically supervised weight management services.
For personalised advice, book a consultation with our team at Private Medical Clinic.
Weight-loss jabs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are now high-risk medications due to concerns about inappropriate prescribing, potential misuse, and supply shortages. This means they require stricter safeguards.
Yes, but you must now go through a proper consultation, including video calls, in-person checks, or verified GP records, before receiving a private prescription.
In most cases, yes. The new rules require prescribers to share prescription details with a patient's GP actively, provided the patient consents.
Online pharmacies must now tighten their prescribing practices, ensure proper patient verification, and avoid misleading advertising. Those who fail to comply may face enforcement actions, including inspections and restrictions on medication supply.
The stricter prescribing criteria apply to other high-risk medications, including antimicrobials, laxatives, and opioids.
A video call is one possible verification method, but the essential requirement is reliable independent verification and an appropriate consultation. The exact process may differ between regulated providers.
An appropriately qualified pharmacist independent prescriber may prescribe it within their competence and governance arrangements. A pharmacist who is not an independent prescriber cannot make the prescribing decision.
Common reasons include an unverified BMI, contraindications, medicine interactions, eating-disorder concerns, pregnancy, insufficient medical information or a request that is not clinically appropriate.
Relevant information should normally be shared with the regular GP with appropriate patient consent. A prescriber may decide not to prescribe if essential information cannot be safely verified or communicated.
Access depends on NICE guidance, NHS commissioning and phased eligibility criteria. Not everyone who may be clinically suitable for private treatment will currently qualify for NHS-funded treatment.
Prescription-only medicines cannot be advertised to the public. A provider may promote a general consultation service, but it must not directly or indirectly promote a named prescription medicine.
Patients should receive dose guidance, planned follow-up, monitoring of weight and side effects, and clear instructions about when to pause treatment or seek medical advice.
Price alone is not a reliable indicator. Check registration, prescriber identity, BMI verification, consultation quality, monitoring and whether the provider makes unrealistic claims.
Tirzepatide has a licensed weight-management indication for eligible adults. Any off-label prescribing requires a clear clinical rationale, informed consent and appropriate monitoring; it should not be used to bypass suitability criteria.
Same Day Online Booking
No Time Limits Appointments
Online Consultations Available
Latest Blog Posts
.avif)
High Cholesterol Warning Signs: What to Look for on Your Face & Body
Liver Function Tests Explained: What Your Results Mean
Full Private Health Check in the UK: What's Included
Decoding Your Blood Test: A Guide to Understanding Your Results
Blood Pressure: What It Is and Why It Matters
Erectile Dysfunction: Causes, Symptoms, Early Signs, and Treatment Options
Ready to take the next step?
Before you go
STRUGGLING WITH HAYFEVER THIS SEASON?
Our hayfever treatment is fast, effective often providing relief within 24 hours.
Book Hayfever Treatment →Book a Hayfever Appointment